Britannia Life Sciences Statistics
Total Valuation
BLSIF has a market cap or net worth of 11.94 million. The enterprise value is 13.10 million.
| Market Cap | 11.94M |
| Enterprise Value | 13.10M |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 162.25M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 37.21% |
| Owned by Institutions (%) | n/a |
| Float | 101.88M |
Valuation Ratios
The trailing PE ratio is 2.02.
| PE Ratio | 2.02 |
| Forward PE | n/a |
| PS Ratio | 63.82 |
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.22 |
| EV / Sales | 68.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.00 |
| Quick Ratio | 0.38 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.52 |
Financial Efficiency
Return on equity (ROE) is -58.92% and return on invested capital (ROIC) is -69.61%.
| Return on Equity (ROE) | -58.92% |
| Return on Assets (ROA) | -10.34% |
| Return on Invested Capital (ROIC) | -69.61% |
| Return on Capital Employed (ROCE) | -37.52% |
| Weighted Average Cost of Capital (WACC) | 3.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 28 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.12 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 6,508 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BLSIF had revenue of 187,079 and earned 5.90 million in profits. Earnings per share was 0.04.
| Revenue | 187,079 |
| Gross Profit | -115,553 |
| Operating Income | -1.96M |
| Pretax Income | -2.38M |
| Net Income | 5.90M |
| EBITDA | -1.89M |
| EBIT | -1.96M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 618,592 in cash and 1.75 million in debt, with a net cash position of -1.13 million.
| Cash & Cash Equivalents | 618,592 |
| Total Debt | 1.75M |
| Net Cash | -1.13M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.63M |
| Book Value Per Share | 0.02 |
| Working Capital | 8,880 |
Cash Flow
| Operating Cash Flow | -3.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -61.77%, with operating and profit margins of -1,050.23% and 3,155.76%.
| Gross Margin | -61.77% |
| Operating Margin | -1,050.23% |
| Pretax Margin | -1,273.99% |
| Profit Margin | 3,155.76% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BLSIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.03% |
| Earnings Yield | 49.45% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BLSIF has an Altman Z-Score of -1.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.55 |
| Piotroski F-Score | 3 |